TRPA1 and hepatocellular carcinoma: This conclusion is supported by the viability-decreasing effect of AITC on CHO cells not expressing the TRPA1 channel and the similar action of AITC in other cancer types 9 HepG2 human hepatocellular carcinoma cells [34] and breast [30], bladder [35], and cervix cancer cells [36].